Global Rheumatic Disorders Drugs Market Grow at (CAGR) of 4.46% to $80.04 billion in 2024

Global Rheumatic Disorders Drugs Market to 2024 research report covers key diseases of rheumatic disorders, market size, therapy area overview, etiology, Epidemiology Patterns and Forecasts - Prevalence and Patient Segmentation and key marketed products.

Pune, India - February 12, 2019 /MarketersMedia/ —

Global Rheumatic Disorders Drugs Market to 2024 - Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry research report added to ReportsnReports online database.
The rheumatic disorder therapy area is multi-disciplinary in nature and encompasses conditions that affect joints, connective tissue, ligaments, tendons, cartilage, bone and muscle and which are characterized by chronic pain and a consequent reduction in function and motion. The majority of rheumatic disorders are treated using largely genericized pain management drugs, and there are no cures for any of the key indications, leaving a large unmet need for better disease-modifying drugs to be developed.

Get Discount on Rheumatic Disorders Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854866

This report covers all rheumatic disorders, but there is a particular focus on five key diseases, rheumatoid arthritis, osteoarthritis, osteoporosis, systemic lupus erythematosus and psoriatic arthritis, as these conditions have the largest pipelines within the therapy area.

The market size for rheumatic disorder therapeutics was $58.97 billion in 2017 and is expected to grow at a compound annual growth rate (CAGR) of 4.46% to $80.04 billion in 2024.

Scope

- How is the rheumatic disorders market landscape expected to change?
- Which drugs will face patent expiry, biosimilar competition and decreasing revenue over the forecast period?
- Overall, there are 1,069 products in the rheumatic disorder pipeline, how does the composition of the pipeline compare with that of the existing market?
- Which molecular targets are most prominent within the pipeline and how do the key indications differ in terms of their pipeline composition?
- The market size for rheumatic disorder therapeutics is expected to grow, from $58.97 billion in 2017 to $80.04 billion in 2024, at a CAGR of 4.46%. Which products will contribute to market growth most, and which will achieve blockbuster status?
- What types of companies are involved in the rheumatic disorder therapy area?
- Will the current market leaders retain their dominance over the forecast period?
- How many strategic consolidations have been completed in the past decade and which types of assets attract the largest deal values?

Reasons to Buy:
This report will allow you to -
- Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis and the treatment options available at each stage of diagnosis for the five key indications
- Understand how the patent expiries of the key, blockbuster anti-TNF drugs will affect the Rheumatic Disorder Drug Market
- Identify trends and developments in the rheumatic disorder pipeline and consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates
- Identify which two drug classes will see particularly strong market growth over the forecast period
- See how or if the companies marketing anti-TNF drugs facing patent expiry will be able to offset biosimilar erosion
- Identify commercial opportunities in the rheumatic disorder deal landscape by analyzing trends in licensing and co-development deals

Direct Purchase of Rheumatic Disorders Drugs Market Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854866

Table of Contents:
1. Introduction
2. Key Marketed Products
3. Pipeline Landscape Assessment
4. Multi-scenario Market Forecast to 2024
5. Company Analysis and Positioning
6. Strategic Consolidations
7. Appendix

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854866-global-rheumatic-disorders-drugs-market-to-2024-increased-uptake-of-il-inhibitors-and-jak-inhibitors-to-drive-growth-as-tnf-inhibitors-face-patent-expiry.html

Source URL: https://marketersmedia.com/global-rheumatic-disorders-drugs-market-grow-at-cagr-of-446-to-8004-billion-in-2024/481750

Source: MarketersMedia

Release ID: 481750

Latest News

Delayed arraignment for suspect in Massachusetts police shooting

Feb 20, 2019

BOSTON (Reuters) - A Massachusetts man suspected of killing a police officer and a bystander with the officer's pistol will not be formally charged on Monday because he is still recovering from wounds sustained during a gunfight with police, officials said.Suspect Emanuel Lopes, 20, was arrested early Sunday after police in Weymouth, Massachusetts, received a report of a person driving erratically. When an officer arrived on the scene, the suspect attacked him with a rock, knocking him to the ground before stealing his gun, shooting the officer and then engaging in a gun battle with other police that left a...

Breitbart lobbying prompted U.S. envoy to raise Tommy Robinson case with British

Feb 20, 2019

(This July 16 story corrects first name of U.S. congressman in paragraph 12 to Paul not Louis)By Mark HosenballLONDON (Reuters) - A representative of U.S. President Donald Trump raised the case of jailed British anti-Muslim activist Tommy Robinson with Britain's ambassador to the United States following lobbying by the right-wing Breitbart.com website, according to a British government source and a pro-Robinson campaigner.Former U.S. Senator Sam Brownback, Trump's Ambassador for International Religious Freedom, told British envoy Sir Kim Darroch at a meeting in June that Breitbart "people" had contacted him about Robinson's imprisonment, the British government source said. Brownback told Darroch...

Boxer Mayweather, George Clooney lead world's highest paid entertainers

Feb 20, 2019

LOS ANGELES (Reuters) - American boxer Floyd Mayweather was named the world's highest-paid entertainer on Monday on a list that saw actor George Clooney take the No. 2 spot with the highest annual pay of his career. Reality star Kylie Jenner, 20, came in third on the annual Forbes Celebrity 100 list, largely thanks to her booming cosmetics line that Forbes said put her on track to become the youngest self-made billionaire in the United States.Forbes compiled its 2018 list estimating pre-tax earnings from June 2017-June 2018, before deducting fees for managers, based on data from Nielsen, touring trade publication...

Boxer Mayweather, George Clooney lead world's highest paid entertainers

Feb 20, 2019

LOS ANGELES (Reuters) - American boxer Floyd Mayweather was named the world's highest-paid entertainer on Monday on a list that saw actor George Clooney take the No. 2 spot with the highest annual pay of his career. Reality star Kylie Jenner, 20, came in third on the annual Forbes Celebrity 100 list, largely thanks to her booming cosmetics line that Forbes said put her on track to become the youngest self-made billionaire in the United States.Forbes compiled its 2018 list estimating pre-tax earnings from June 2017-June 2018, before deducting fees for managers, based on data from Nielsen, touring trade publication...

Tesla shares fall after CEO Musk abuses British caver

Feb 20, 2019

(Reuters) - Shares of Tesla Inc fell over 3.5 percent on Monday after Chief Executive Elon Musk directed abuse on Twitter at one of the British cavers involved in the rescue of 12 Thai children last week.A number of analysts and investors, requesting anonymity, told Reuters that Musk's comments were adding to their concerns that his public statements were distracting him from Tesla's main business of producing electric cars. The stock sell-off knocked almost $2 billion off the company's market value.Tesla shares were at $307.20 in after-hours trading on Monday from Friday's close of $318.87. James Anderson, a partner at...

About Us

In the busy city of New York, News On Express fills you in with all the breaking world news, in short, and brief news articles so that you can read them on-the-go.

Contact us: sales[at]newsonexpress.com

Subscribe Now!